Related Experiment Video
Updated: Jul 6, 2026
Anteromesial Temporal Lobectomy for Medically Intractable Temporal Lobe Epilepsy: An Operative Study
Published on: August 15, 2025
Temporal lobe epilepsy surgery and the quest for optimal extent of resection: a review
1Department of Neurosurgery, Bonn University Medical Center, University of Bonn, Bonn, Germany. Johannes.Schramm@ukb.uni-bonn.de
Abstract:
The efficacy of surgery to treat drug-resistant temporal lobe epilepsy (TLE) has been demonstrated in a prospective randomized trial. It remains controversial which resection method gives best results for seizure freedom and neuropsychological function. This review of 53 studies addressing extent of resection in surgery for TLE identified seven prospective studies of which four were randomized. There is considerable variability between the intended resection and the volumetrically assessed end result. Even leaving hippocampus or amygdalum behind can result in seizure freedom rates around 50%. Most authors found seizure outcome in selective amygdalohippocampectomy (SAH) to be similar to that of lobectomy and there is considerable evidence for better neuropsychological outcome in SAH. Studies varied in the relationship between extent of mesial resection and seizure freedom, most authors finding no positive correlation to larger mesial resection. Electrophysiological tailoring saw no benefit from larger resection in 6 of 10 studies. It must be concluded that class I evidence concerning seizure outcome related to type and extent of resection of mesial temporal lobe structures is rare. Many studies are only retrospective and do not use MRI volumetry. SAH appears to have similar seizure outcome and a better cognitive outcome than TLR. It remains unclear whether a larger mesial resection extent leads to better seizure outcome.
Insights
Surgery for drug-resistant temporal lobe epilepsy (TLE) shows promise. Selective amygdalohippocampectomy (SAH) offers similar seizure control and better cognitive outcomes compared to temporal lobe resection (TLR).
Area of Science:
- Neurosurgery
- Epileptology
- Clinical Neurology
Background:
- Drug-resistant temporal lobe epilepsy (TLE) poses significant challenges.
- Surgical interventions are established treatments, but optimal methods remain debated.
- The extent of resection and its impact on seizure control and cognitive function require clarification.
Purpose of the Study:
- To review the evidence on the extent of resection in temporal lobe epilepsy surgery.
- To compare seizure freedom and neuropsychological outcomes between different surgical techniques.
- To evaluate the correlation between resection extent and patient outcomes.
Main Methods:
- Systematic review of 53 studies on TLE surgery extent.
- Identification and analysis of seven prospective studies, including four randomized trials.
- Assessment of variability between intended and actual resection volumes using MRI volumetry.
Main Results:
- Seizure freedom rates around 50% are achievable even with partial resection of the hippocampus or amygdala.
- Selective amygdalohippocampectomy (SAH) demonstrates comparable seizure outcomes to lobectomy with improved neuropsychological results.
- No consistent positive correlation was found between larger mesial resection extent and improved seizure freedom.
- Electrophysiological tailoring did not show benefits from larger resections in most studies.
Conclusions:
- High-quality evidence (Class I) on the relationship between resection extent and seizure outcome in TLE is limited.
- Retrospective studies lacking MRI volumetry are common.
- SAH appears to be a favorable surgical option for TLE, offering similar seizure control and better cognitive outcomes than temporal lobe resection (TLR).
- The necessity of larger mesial resection for enhanced seizure control remains uncertain.
